Larimar Therapeutics (ZA71.STU) Q3 2026 Earnings

6AugConfirmed
Q2 2026
Next
-0.46
-0.39
-0.33
-0.27

Details

Expected EPS
-0.342154064
Actual EPS
N/A
Surprise EPS
0.34
Surprise Percent
+100%

Description

Larimar Therapeutics (ZA71.STU) will report earnings of for Q3 2026 on August 06, 2026.

0 Comments

Share your thoughts